|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2007-10-9
|
|
pubmed:abstractText |
The combination of docetaxel/gemcitabine is an acceptable chemotherapy regimen for the treatment of non-small cell lung cancer. An economic evaluation is undertaken alongside a multi-centre randomized phase III trial, which compares docetaxel/gemcitabine combination with docetaxel monotherapy, in untreated patients with advanced/metastatic non-small cell lung cancer.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0169-5002
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
58
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
275-81
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:17688969-Adult,
pubmed-meshheading:17688969-Antineoplastic Agents,
pubmed-meshheading:17688969-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:17688969-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:17688969-Cost-Benefit Analysis,
pubmed-meshheading:17688969-Deoxycytidine,
pubmed-meshheading:17688969-Drug Toxicity,
pubmed-meshheading:17688969-Female,
pubmed-meshheading:17688969-Greece,
pubmed-meshheading:17688969-Humans,
pubmed-meshheading:17688969-Kaplan-Meier Estimate,
pubmed-meshheading:17688969-Lung Neoplasms,
pubmed-meshheading:17688969-Male,
pubmed-meshheading:17688969-Middle Aged,
pubmed-meshheading:17688969-Neoplasm Metastasis,
pubmed-meshheading:17688969-Neoplasm Staging,
pubmed-meshheading:17688969-Taxoids
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Economic evaluation of docetaxel/gemcitabine versus docetaxel as frontline treatment of patients with advanced/metastatic non-small cell lung cancer in Greece.
|
|
pubmed:affiliation |
Department of Medical Oncology, University General Hospital of Heraklion, Voutes 71110, Crete, Greece. nmaniadakis@yahoo.com
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Randomized Controlled Trial,
Clinical Trial, Phase III
|
